https://www.marketscreener.com/quote/stock/4SC-AG-22033427/news/4SC-AG-First-Patient-Enrolled-in-DONIMI-Study-Evaluating-Domatinostat-in-the-Neoadjuvant-Setting-in-29838518/?utm_source=telegram&utm_medium=social&utm_campaign=share